Spatial transcriptomics maps resident cardiac macrophages across the earliest infarct window
Acute myocardial infarction does not unfold as a single immunologic event. It moves through a sequence of inflammatory, proliferative, and reparative phases, and resident cardiac macrophages sit inside every one of them. In this mouse ischemia/reperfusion model, investigators traced how resident cardiac macrophages changed during the first days after injury and linked those shifts to spatially defined tissue programs inside the injured heart.
The central observation was not simply that macrophage genes changed after infarction. The more important finding was that those changes were organized in time and space, with distinct transcriptional states appearing in the cardiac compartment as injury matured. Early after reperfusion, inflammatory and reparative gene programs emerged together, then overlaid with extracellular matrix signals in the zones most affected by damage. The infarct was not a uniform field of injury; it was a patchwork of immune activity, repair, and fibrosis in motion.
Early ischemia/reperfusion injury reshaped macrophage programs rather than eliminating them outright
The study used a temporary left anterior descending coronary artery ligation in six- to eight-week-old male C57BL/6 mice, followed by reperfusion after 30 minutes. Hearts were collected at 2 and 4 days after injury, a window that captures the transition from the inflammatory phase into the early reparative period. Resident cardiac macrophages were isolated by flow cytometry and profiled with NanoString, while whole-tissue sections underwent Visium spatial transcriptomic analysis.
This design matters because resident macrophages are not passive bystanders in infarction. Under steady-state conditions, they support coronary plexus remodeling, vascular maturation, conduction, and immunosurveillance. After ischemic necrosis and reperfusion, damage-associated molecular patterns flood the tissue and resident macrophages are rapidly reduced, while infiltrating monocyte-derived macrophages expand. The heart therefore shifts from a resident-cell-dominant immune environment to one shaped by incoming myeloid cells and a changing local cytokine milieu. The transcriptomic readout in this study reflects that biological churn.
One sentence captures the practical consequence: the macrophage compartment in early infarction is rebuilt, not merely depleted.
NanoString profiling pointed to inflammatory, reparative, and extracellular matrix pathways
NanoString analysis of pooled resident cardiac macrophage samples identified candidate differentially expressed genes across time points. Pathway enrichment then organized those signals into broader functional themes, including inflammatory, reparative, and extracellular matrix-associated programs. The result is biologically coherent with what is known about infarct healing: the same myeloid population that helps clear debris and contain tissue injury can also participate in later remodeling that turns helpful repair into maladaptive scar formation.
The article does not present the transcriptomic shifts as abstract biomarkers. It positions them as markers of a cellular sequence that likely governs bedside outcomes—whether the healing myocardium resolves inflammation, preserves structure, or drifts toward fibrosis and adverse remodeling. The extracellular matrix signal is especially relevant in this setting because collagen deposition is not a late, isolated event; it is already being negotiated in the early days after infarction, when macrophage phenotypes are still changing.
S100a9-associated biology stood out within this framework. Integration of NanoString, spatial transcriptomics, and immunostaining revealed temporal and spatial patterns of S100a9-associated macrophage signatures during early AMI. In practical terms, that places a recognized inflammatory marker inside a live tissue map of infarct evolution rather than leaving it in bulk tissue averages.
Spatial transcriptomics uncovered six macrophage-associated states inside the cardiac compartment
Visium analysis added the missing tissue architecture. Spatial transcriptomics identified patterns consistent with six macrophage-associated transcriptional states within the heart. Rather than blending all myeloid activity into a single signal, the method separated the injured myocardium into biologically distinct regions where macrophage programs tracked with local tissue context.
The co-localization of macrophage-associated transcripts and fibrosis-associated transcripts in injured areas is one of the most clinically relevant observations in the paper. It suggests that the macrophage response and the fibrotic response are not serial events separated by a clean boundary. They appear together in space, and likely interact as the tissue boundary between salvage and scar is being established. In a reperfused infarct, that interaction may shape whether the wound closes with adaptive repair or excessive matrix deposition.
Spatial biology carries added value here because macrophage function is highly dependent on microenvironment. A macrophage adjacent to viable border-zone myocardium may behave differently from one embedded in a necrotic core or a collagen-rich repair zone. By tying gene expression to tissue geography, the study gives a more realistic picture of infarct immunobiology than dissociated-cell sequencing alone can provide.
Why resident cardiac macrophages matter in infarct healing
Resident cardiac macrophages begin life in the embryo and persist through self-renewal in the healthy heart. Their depletion during ischemic injury is part of the reason the inflammatory response becomes harder to contain. Monocyte-derived macrophages then flood the tissue and partially replace that resident population, but the replacement is not exact. Those incoming cells can recapitulate some resident functions, yet the balance of pro-inflammatory, anti-inflammatory, and fibrogenic behavior shifts as the infarct ages.
This study fits squarely into that framework by showing that resident macrophage-associated signals are still detectable and biologically informative during early AMI. Their transcriptomic programs are not static markers of a lost population. They are active readouts of how the heart is trying to manage debris clearance, immune activation, repair, and scar formation at the same time.
The tissue-level implication is direct. A therapy that selectively alters inflammatory macrophage behavior without considering reparative and fibrotic states could miss the biology that determines ventricular remodeling. The same cell population may be helping at one stage and harming at another, depending on where it sits in the infarct and which transcriptional program it is expressing.
What this mouse model can and cannot answer yet
The study offers a detailed map of early macrophage-associated transcriptional states, but it remains a mouse study based on a controlled ischemia/reperfusion model. The analysis covered hearts at control, 2 days, and 4 days after injury, with resident macrophage samples pooled for NanoString from three hearts per time point. Those design choices support pathway discovery, yet they do not by themselves establish human disease equivalence or causal function.
Even so, the data are valuable because they connect three layers of evidence: isolated resident macrophage transcription, whole-tissue spatial context, and immunostaining for S100A9 and macrophage markers. The concordance across those layers strengthens the inference that macrophage states evolve in a structured way during early AMI rather than changing randomly across the myocardium.
The immediate research need is mechanistic validation of the inflammatory, reparative, and fibrosis-linked states identified here. The GEO deposit, GSE333790, gives other investigators a route to reanalyze the dataset, but the clinical question remains unresolved: which of these macrophage-associated programs is protective, which is harmful, and which can be targeted without disturbing the repair process that stabilizes the infarcted heart.